Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
Status: | Terminated |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | February 2009 |
End Date: | March 2013 |
The Process and Outcomes of Treatment Decision-Making Communication Between Oncologists and Newly Diagnosed Female Breast-Cancer Patients
RATIONALE: A study that looks at communication between patients and doctors may help
oncologists improve patient satisfaction with their treatment plan.
PURPOSE: This phase I trial is studying treatment decision making between oncologists and
women with newly diagnosed breast cancer and their healthy companions.
oncologists improve patient satisfaction with their treatment plan.
PURPOSE: This phase I trial is studying treatment decision making between oncologists and
women with newly diagnosed breast cancer and their healthy companions.
OBJECTIVES:
Primary
- To determine the association between women's and physicians' participatory
communication behaviors (e.g., patients asking questions, physicians soliciting
questions) on treatment decision-making process and health outcomes.
Secondary
- To capture the language used in the treatment-decision interactions.
- To assess the degree of variation in the language used among physicians and patients
who are active participants and those who are less inclined to participate in the
treatment decision-making interaction.
OUTLINE: Patients and their companions undergo consultation with the physician for treatment
decision making. The treatment discussion is audio/videotaped for approximately 45 minutes.
Patients complete one short survey prior to physician consultation. After the treatment
discussion, patients complete two short surveys, one immediately after the visit in the
waiting room before leaving for the day, and the second one a week after the visit by a
web-based survey or by mail.
PROJECTED ACCRUAL: A total of 300 women with breast cancer and 600 companions of these women
will be accrued for this study.
Primary
- To determine the association between women's and physicians' participatory
communication behaviors (e.g., patients asking questions, physicians soliciting
questions) on treatment decision-making process and health outcomes.
Secondary
- To capture the language used in the treatment-decision interactions.
- To assess the degree of variation in the language used among physicians and patients
who are active participants and those who are less inclined to participate in the
treatment decision-making interaction.
OUTLINE: Patients and their companions undergo consultation with the physician for treatment
decision making. The treatment discussion is audio/videotaped for approximately 45 minutes.
Patients complete one short survey prior to physician consultation. After the treatment
discussion, patients complete two short surveys, one immediately after the visit in the
waiting room before leaving for the day, and the second one a week after the visit by a
web-based survey or by mail.
PROJECTED ACCRUAL: A total of 300 women with breast cancer and 600 companions of these women
will be accrued for this study.
DISEASE CHARACTERISTICS:
- Meets one of the following criteria:
- Woman with newly diagnosed early-stage breast cancer
- Caregiver or companion willing to participate in study
PATIENT CHARACTERISTICS:
- Speaks native English or has learned to speak English fluently
- Patient's companion ≥ 18 years old (if applicable)
- Able to complete questionnaires without assistance
- Not pregnant
PRIOR CONCURRENT THERAPY:
- Not specified
We found this trial at
1
site
195 Little Albany St
New Brunswick, New Jersey 08903
New Brunswick, New Jersey 08903
(732) 235-2465
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School As New...
Click here to add this to my saved trials